HeartSciences (HSCS) Cash from Operations (2021 - 2026)

HeartSciences has reported Cash from Operations for 6 years, with the latest figure at 1462526.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 9.73% year-over-year to 1462526.0; the trailing twelve-month figure through Jan 2026 stood at 7340799.0 (up 0.79% YoY), and the FY2025 full-year result was 7412994.0, down 22.12% from the prior year.
• Cash from Operations for Q1 2026 stood at 1462526.0, up from 2334266.0 in the prior quarter.
• The five-year high for Cash from Operations was 966278.0 in Q1 2022, with the low at 2334266.0 in Q4 2025.
• Historically, Cash from Operations has averaged 1597971.47 across 5 years, with a median of 1590640.0 in 2025.
• Annual changes were most pronounced in 2022 — Cash from Operations sank 152.51% — and 2025, when it advanced 22.89%.
• HeartSciences' Cash from Operations stood at 1080141.0 in 2022, then advanced by 8.51% to 988187.0 in 2023, then tumbled by 120.97% to 2183550.0 in 2024, then retreated by 6.9% to 2334266.0 in 2025, then surged by 37.35% to 1462526.0 in 2026.
• The last three Cash from Operations figures came in at 1462526.0 (Q1 2026), 2334266.0 (Q4 2025), and 1953367.0 (Q3 2025), per Business Quant data.